LEADER 04208nam 2200985z- 450 001 9910639995803321 005 20231214132825.0 010 $a3-0365-6019-X 035 $a(CKB)5470000001633395 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/95804 035 $a(EXLCZ)995470000001633395 100 $a20202301d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFunctional Nanomaterials in Biomedicine 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (260 p.) 311 $a3-0365-6020-3 330 $aThe great success of nanotechnology promotes a tremendous revolution in the biomedical field. Functional nanomaterials have been widely applied for the treatment of various diseases, such as cancer, bacterial infection, diabetes, inflammation, and neurodegenerative disorders. Various therapeutic nanoplatforms have been developed with therapeutic functions and intelligent properties. However, the development of nanomedicine suffers from several challenges prior to their clinical applications. For instance, disease detection in an early stage is a critical challenge for nanomedicine. It is difficult to detect disease markers (e.g., proteins, genes, or cancer circulating cells), so nanoprobes with high sensitivity and selectivity are required. Moreover, to overcome drug resistance, it is highly desirable to develop functional nanomedicines with the combination of multiple therapeutic modalities, such as chemotherapy, photothermal therapy, photodynamic therapy, chemodynamic therapy, radiotherapy, starving therapy, and immunotherapy. Additionally, the stability and degradability of most nanomedicines in biofluids should be carefully evaluated before their administration to humans. This book provides researchers with the latest investigations and findings in this field. 606 $aMedical equipment & techniques$2bicssc 610 $atumor microenvironment 610 $atargeted therapy 610 $ananoparticles 610 $anano therapeutics 610 $atumor imaging 610 $acell membrane coated nanoparticle 610 $aatherosclerosis 610 $athrombosis 610 $adiagnosis and therapy 610 $acardiovascular disease 610 $aFe-based nanoparticles 610 $aendosomal pH-responsive hyaluronate 610 $aCD44 receptor-mediated endocytosis 610 $atumor therapy 610 $aAlzheimer disease's 610 $aamyloid-? 610 $ananomaterials 610 $aphotothermal therapy 610 $aphotodynamic therapy 610 $abiomedical imaging 610 $aiodinated contrast media 610 $aX-ray computed tomography 610 $aorganic nanoparticles 610 $aiodinated polymers 610 $aSARS-CoV-2 main protease 610 $acolorimetry 610 $aelectrochemical impedance spectroscopy 610 $agold nanoparticles 610 $aselenium 610 $aselenium nanoparticles 610 $aantioxidant activities 610 $aclean-up procedure 610 $aglutathione 610 $aParkinson's disease 610 $aL-DOPA 610 $acurcumin 610 $ananozyme 610 $asingle-atom nanozyme 610 $asurface modification 610 $aROS scavenging 610 $aantibacterial 610 $aelectrostatic spinning 610 $ainorganic nanocrystals 610 $apolymer fibers 610 $aantimicrobial 610 $abiomedical 610 $agraphene 610 $ananocomposites 610 $amultimodal imaging 610 $aphototherapy 610 $atheranostics 610 $acancer 610 $abacterial infection 615 7$aMedical equipment & techniques 700 $aChen$b Wansong$4edt$01279883 702 $aZhang$b Jianhua$4edt 702 $aChen$b Wansong$4oth 702 $aZhang$b Jianhua$4oth 906 $aBOOK 912 $a9910639995803321 996 $aFunctional Nanomaterials in Biomedicine$93016108 997 $aUNINA